Mitsubishi Pharma Corporation (Merger Between Welfide Corporation And Mitsubishi-Tokyo Pharmaceuticals, Inc.)
Mitsubishi Welpharma Kabushiki Kaisha (In Japan)
2-6-9, Hiranomachi
Chuo-ku
Osaka
541-0046
Tel: 81-6-6201-1600
Fax: +81-6-6233-2516
Website: http://www.m-pharma.co.jp/
15 articles about Mitsubishi Pharma Corporation (Merger Between Welfide Corporation And Mitsubishi-Tokyo Pharmaceuticals, Inc.)
-
Mitsubishi Pharma Corporation JV Building $20 Million Plant in Tianjin
8/8/2013
-
Genelabs Technologies, Inc. Regains Exclusive Rights to Prestara(TM) in Japan From Mitsubishi Pharma Corporation
11/19/2007
-
Quark Pharmaceuticals Inc. to Receive Development Milestone Payment From Mitsubishi Pharma Corporation
10/9/2007
-
BioWisdom Announces Mitsubishi Pharma Corporation to use BioWisdom KnowledgeScan(TM)
6/5/2007
-
Medarex, Inc. Announces Collaborative Research Agreement with Mitsubishi Pharma Corporation
5/31/2007
-
BrainCells, Inc. In-Licenses Clinical-Stage CNS Compound From Mitsubishi Pharma Corporation
8/10/2006
-
Mitsubishi Pharma Corporation To Establish Pharmaceutical Development Company In Beijing, New Jobs
5/15/2006
-
BG Medicine To Conduct Joint Biomarker Discovery Study For Muscle Toxicity With Mitsubishi Pharma Corporation
3/27/2006
-
Mitsubishi Pharma Corporation To License ZIONE Internal Hemorrhoid Drug To Yuhan Corporation
2/24/2006
-
AVEO Pharmaceuticals, Inc. Acquires Rights To Novel Anti-Cancer Compound From Mitsubishi Pharma Corporation
1/5/2006
-
Mitsubishi Pharma Corporation Announces Drug Discovery Collaboration With Discovery Partners International Inc.
10/26/2005
-
Learnwright Forms Strategic Alliance With Mitsubishi
10/15/2004
-
Learnwright, Inc Release: Learnwright Forms Strategic Alliance With Mitsubishi
10/12/2004
-
Gurus Find Portfolio Cures In Biotech
6/16/2004
-
Astex Deal With Boehringer Worth Up To $45M Per Target
3/17/2004